Allergy Diagnostics Market

The allergy diagnostic market is projected to reach USD 10.77 billion by 2031, up from USD 6.80 billion in 2026, at a CAGR of 9.6%.The rise in allergic disorders worldwide has been remarkable over the last few years. These disorders include allergic rhinitis, asthma, atopic dermatitis, and food allergies. The rise of allergies worldwide has been driven by a combination of genetic susceptibility and environmental factors, including increased urbanization, pollution, and changing lifestyle patterns. As a result of people having symptoms such as sneezing, itching, wheezing, and digestive discomfort, the need for precise and timely diagnosis becomes critical. Allergy diagnostics are useful for distinguishing between allergens, thus allowing targeted treatment or only symptomatic relief. For instance, detection of IgE sensitivity to certain pollens or foods enables doctors to advise avoidance, immunotherapy, or personalized pharmacological treatments. In areas where pollen concentrations are high, e.g., some parts of North America and Europe, the fraction of people suffering from seasonal allergies is very high; thus, the local authorities are encouraged to provide screening and management for the whole population. Likewise, recognition of food allergies in kids is on the rise, so pediatric departments are emphasizing diagnostic tests to avoid prescribing long-term avoidance diets that may cause nutritional deficiencies.

With the increase in the prevalence of diseases, both patients and clinicians are demanding more comprehensive panels, molecular diagnostics, and highly accurate tests that can minimize the trial-and-error approach in treatments. This growing burden of the disease is creating a continuous and expanding market opportunity for diagnostic providers, laboratories, and point, of, care test manufacturers. This report segments the allergy diagnostic market by product & service, test type, allergen, end user, and region.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in this market include Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Minaris Medical America, Inc. (US), Omega Diagnostics Group Plc (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (Germany), HollisterStier Allergy (US), Eurofins Scientific (Luxembourg), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), Erba Group (UK), Alcit India Pvt. Ltd. (India), Biopanda Reagents (UK), Bioside S.r.l. (Italy), Creative Diagnostic Medicare Pvt. Ltd. (India), DST Diagnostische Systeme & Technologien GmbH (Germany), and Dr. Fooke Laboratorien GmbH (Germany).

Thermo Fisher Scientific Inc. (US)

The company's strong market position is mainly attributed to its excellent product portfolio. It offers Phadia instruments that laboratories and healthcare settings use extensively for allergy testing. The company also has a strong geographic presence, which contributes to its wide customer base. Thermo Fisher Scientific Inc. currently serves over 400,000 customers in various sectors, including pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial quality and process control settings.

Danaher Corporation (US)

Danaher operates in this market through its subsidiary, Beckman Coulter, which falls under the Core Lab Diagnostics business subsegment. The Core Lab business provides biomedical testing instruments, systems, and related consumables to end users, which help evaluate and analyze body fluids, cells, and other substances. The information generated from these tests is used to diagnose diseases, monitor and guide treatment and therapy, manage chronic diseases, and assess patient status in hospital, outpatient, and physicians’ office settings. Beckman Coulter offers a wide range of products, including consumables and instruments for allergy testing.

Siemens Healthineers AG (Germany)

Siemens Healthineers has strategically focused on strengthening its immunodiagnostics portfolio to address rising allergy prevalence and increasing demand for laboratory-based testing. The company has expanded assay menus, improved analyzer throughput, and invested in laboratory automation to support higher test volumes and centralized diagnostic models. Digital connectivity and data management solutions have been integrated to optimize laboratory workflows and reduce turnaround times. Inorganic growth and partnerships have complemented internal R&D efforts, enabling access to additional diagnostic capabilities and reinforcing its position in core IVD segments aligned with the shift from in-vivo to in-vitro allergy diagnostics.

Market Ranking

The allergy diagnostic market is highly competitive, with prominent players accounting for over 35% of the total market share in 2025. Some players dominating the market include Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Revvity (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG) (Germany), and Canon (Minaris Medical America, Inc.) (US).

The allergy diagnostic market is characterized by the presence of strong regional manufacturers, particularly across the Asia Pacific, including China and India, alongside a limited number of multinational players with localized manufacturing and distribution footprints. Regional companies have significantly enhanced their core product portfolios, especially immunoassay kits, consumables, and compact analyzers, while improving assay accuracy, turnaround time, and regulatory compliance to remain competitive on pricing and accessibility. Over the past few years, increased awareness of allergic disorders, rising diagnostic testing volumes, and expansion of laboratory infrastructure have supported this shift. Additionally, improving healthcare access and investments in diagnostic capabilities across emerging economies are encouraging both local and global players to strengthen their regional presence and optimize supply chains to meet growing demand.

Related Reports:

Allergy Diagnostic Market by Product & Service (Consumables, Instruments [Immunoassay Analyzers, Luminometers]), Test Type (In Vivo Tests, In Vitro Tests), Allergen (Food Allergens), End User (Hospital-Based Laboratories) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com